Study of SYN023 for children exposed to rabies
Part of Infections clinical trials.
This study looks at how well the rabies treatment SYN023 works in children under 18 who have had a high-risk (Category III) animal bite. It tests a combination of medications given right after the bite to prevent rabies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 18 years old
- You had a high-risk rabies exposure (like a bite from a dog or other animal) within the last 7 days
- You have already started treatment with wound care, rabies shots, and the study medicine within the past 24 hours
- Your parent or guardian agrees to the study and you agree if you are 8 or older
- You can complete all study visits, including rabies shots and follow-up for one year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial provides access to an experimental medicine (SYN023) for people with rabies who have no other options. It aims to treat the infection, but since there is no standard cure, this is a special program for urgent cases.
This study tests a new rabies vaccine given after a possible exposure to rabies (like a bite) to see how well it works and how safe it is. The vaccine is given in a series of shots to help your body fight the rabies virus.
This trial tests whether different batches of a rabies vaccine produce the same immune response. You would receive the vaccine and have blood tests to check your antibody levels, helping ensure the vaccine works consistently.
This study tests how well a rabies vaccine works and how safe it is for people whose immune systems may be weaker, such as those with certain long-term illnesses, organ transplants, or age 60 and older. It compares them to healthy adults ages 18 to 59.
This study tests a new rabies vaccine given before any exposure to the virus, to help prevent infection. It aims to see if the vaccine is safe and creates a strong immune response in healthy people.
This trial tests different doses of a rabies vaccine to see how well they protect against rabies and how safe they are. It's for healthy adults who may need rabies protection, for example after an animal bite or as routine prevention.
Hear when a new Rabies Post-exposure Prophylaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.